Back to VA Vanguard Capital Management LLC
LYEL
2 quarters
Position history for VAVanguard Capital Management LLC's holdings in Lyell Immunopharma, Inc.
Yes. Vanguard Capital Management holds 786,774 shares of LYEL (Lyell Immunopharma), worth $11.1M, as of its Q2 2026 13F filing. It increased the position by 68,619 shares (+9.6%) from Q1 2026. Vanguard Capital Management has held LYEL in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$11.1M
Current Shares
786,774
Total Value Change
-$3.4M
Total Shares Change
+68,619
Quarter-by-Quarter History
Other major holders of LYEL: Vanguard Group Inc., BlackRock, Inc., Citadel Advisors LLC, Millennium Management LLC